硬式内视镜市场 - 全球产业规模、份额、趋势、机会及预测（按产品、最终用户、地区和竞争格局划分，2021-2031年）

全球硬式内视镜市场预计将从 2025 年的 73.6 亿美元成长到 2031 年的 106.8 亿美元，年复合成长率为 6.41%。

这些由非弹性导管和光纤传输装置组成的光学仪器，对于在腹腔镜和关节镜等微创手术中观察体腔至关重要。市场成长的主要驱动力是缩短住院时间的外科技术发展趋势以及需要医疗干预的慢性疾病病例的增加。例如，美国癌症协会估计，到2025年，美国将新增约2,041,910例癌症病例。如此沉重的疾病负担正在推动泌尿系统和一般外科领域对精准可视化仪器的持续需求。

然而，可重复使用仪器的再处理及其相关的交叉感染风险，为市场带来了许多障碍。为防止医院感染而必须严格执行的消毒通讯协定，往往会造成操作上的挑战和监管上的复杂性。此外，先进诊断影像系统所需的大量资金投入，也阻碍了其普及，尤其对于预算有限的医疗机构而言更是如此。

市场驱动因素

机器人辅助内视镜系统的日益普及正成为市场扩张的主要催化剂，因为这些平台高度依赖先进的硬式内视镜，以在复杂的手术过程中提供三维视觉化。随着医疗机构采用机器人技术来提高妇科、泌尿系统和一般外科的手术精度，这些光学仪器的使用量正在显着增长。主要机器人系统供应商的业绩也印证了这个趋势。直觉外科公司（Intuitive Surgical）在2025年1月报告称，到2024年，全球使用达文西手术系统进行的手术数量将达到约268.3万例，比上一年增长17%。手术量的强劲成长凸显了硬式内视镜在现代机器人手术环境中发挥的关键作用。

同时，高画质和3D成像技术的创新正在加速设备更新换代，并推动微创手术的应用。诸如4K影像等功能使外科医生能够更精准地识别病灶，从而改善临床疗效并提高工作流程效率。这为主要行业参与者带来了显着的经济效益。例如，Olympus Corporation在2024年5月公布，截至2024年3月的财年，其内视镜解决方案业务销售额达到5,866亿日元，年增6.3%。此外，需要诊断干预的疾病发生率不断上升，也给医疗资源带来了压力。根据英国国家医疗服务体系（NHS）2024年的数据，11月有19.9%的病患等待诊断检测的时间超过六週，凸显了对内视镜技术的持续需求。

市场挑战

先进的硬式内视镜及相关诊断影像系统需要大量的资金投入，这构成了市场推广的一大障碍。医疗机构通常面临严格的预算限制，难以购买昂贵的医疗设备。当最新的视觉化工具需要高昂的前期成本时，医院往往会推迟升级或继续使用旧设备。这种对新技术投资的抵触情绪直接限制了製造商的收入潜力，并减缓了先进内视镜解决方案在全球市场的渗透速度。

不断上涨的营运成本进一步加剧了这种财务压力，营运成本占了医疗保健预算成长的很大一部分。根据美国医院协会 (AHA) 预测，到 2024 年，医院总支出预计将增加 5.1%，远超整体通货膨胀率。这种经济负担迫使决策者优先考虑维持日常运营，而非对外科器械进行资本投资。因此，许多医疗机构无法负担这些不断上涨的成本，导致其购买力下降，并阻碍了整个硬式内视镜市场的成长。

市场趋势

随着医疗服务提供者寻求更具成本效益的住院治疗替代方案，内视镜手术向门诊手术中心（ASC）的转移正在改变市场格局。这种转变在关节镜和腹腔镜等硬式内视镜手术中尤其明显，门诊手术中心精简的工作流程能够提高手术量并降低营运成本。有利的报销政策以及专为小规模环境设计的紧凑型高性能视觉化系统的普及，进一步推动了这一转变。正如门诊手术中心协会在2024年7月指出的那样，预计2024年至2034年间，门诊手术中心的手术量将增长21%，达到4400万例。这促使製造商积极开发针对不断增长的门诊领域的专业服务模式和设备。

同时，萤光引导成像系统的进步使外科医生能够比使用标准白光内视镜更精确地观察解剖结构。近红外线萤光技术能够即时评估组织灌注情况，并在复杂的腹腔镜手术中识别胆管，从而推动了对这些先进光学功能的需求。这项技术革新满足了提高术中安全性的迫切需求，并推动了领先设备製造商的收入成长。根据史赛克公司2025年1月发布的报告，该公司预计其内视镜业务在2024财年将实现全球两位数的有机销售增长，这凸显了集成萤光功能的下一代成像平台在改善临床疗效方面的加速普及。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球硬式内视镜市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品分类（腹腔镜、关节镜、输尿管镜、膀胱镜、妇科内视镜、神经内视镜、神经科学用内视镜、子宫镜镜、喉镜、鼻窦镜、耳镜、乙状结肠镜、咽镜、十二指肠镜、鼻咽镜、鼻内视镜）
  • 按最终使用者（医院/诊所、门诊护理中心、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章 北美硬式内视镜市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

第七章 欧洲硬式内视镜市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章 亚太地区硬式内视镜市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲硬式内视镜市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲硬式内视镜市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球硬式内视镜市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Olympus Corporation
• Ethicon, Inc.
• Boston Scientific Corporation
• Karl Storz SE & Co. KG
• Stryker Corporation
• PENTAX Medical Singapore Pte Ltd
• Richard Wolf GmbH
• ATMOS MedizinTechnik GmbH & Co. KG
• XION GmbH
• EndoMed Systems GmbH

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Rigid Endoscopes Market is projected to expand from a valuation of USD 7.36 Billion in 2025 to USD 10.68 Billion by 2031, reflecting a CAGR of 6.41%. These optical devices, which consist of a non-flexible tube and a light transmission mechanism, are essential for visualizing internal cavities during minimally invasive interventions like laparoscopy and arthroscopy. Market growth is largely sustained by a preference for surgical methods that reduce hospital stays and the increasing prevalence of chronic conditions requiring medical intervention. For instance, the American Cancer Society estimates that approximately 2,041,910 new cancer cases will occur in the United States in 2025. This substantial disease burden drives a persistent demand for accurate visualization instruments in urology and general surgery.

Nevertheless, the market encounters significant obstacles related to the reprocessing of reusable instruments and the associated danger of cross-contamination. Strict sterilization protocols needed to prevent hospital-acquired infections often create operational difficulties and regulatory complexities. Furthermore, the substantial capital expenditure required for advanced imaging systems presents a barrier to adoption, particularly for healthcare facilities that must operate within limited budgets.

Market Driver

The growing integration of robot-assisted endoscopic systems acts as a major catalyst for market expansion, as these platforms depend heavily on advanced rigid endoscopes to provide 3D visualization during complex procedures. As medical facilities adopt robotic technologies to improve surgical precision in gynecology, urology, and general surgery, the usage of these optical instruments has increased substantially. This trend is evident in the performance of major robotic system providers; Intuitive Surgical reported in January 2025 that roughly 2,683,000 surgical procedures were conducted globally using da Vinci systems in 2024, marking a 17% rise from the previous year. Such robust procedural growth highlights the essential role of rigid endoscopy within the modern robotic surgical landscape.

Simultaneously, innovations in high-definition and 3D imaging are accelerating device replacement cycles and adoption in minimally invasive surgeries. Features such as 4K visualization allow surgeons to identify pathologies with greater accuracy, thereby enhancing clinical outcomes and workflow efficiency, which has generated significant financial returns for key industry players. For example, Olympus Corporation reported in May 2024 that revenue in its Endoscopic Solutions Business hit ¥586.6 billion for the fiscal year ending March 31, 2024, a 6.3% year-on-year increase. Additionally, the rising incidence of disorders requiring diagnostic intervention strains healthcare resources; NHS England data from 2024 indicated that 19.9% of patients waited six weeks or more for diagnostic tests in November, emphasizing the continued need for endoscopic capacity.

Market Challenge

The substantial capital investment required for advanced rigid endoscopes and their accompanying imaging systems constitutes a major hurdle to market adoption. Healthcare facilities frequently function under strict budget limitations, restricting their ability to procure expensive medical capital equipment. When confronted with high upfront costs for modern visualization tools, hospitals often postpone upgrades or persist in using legacy devices. This hesitation to invest in new technology directly limits the revenue potential for manufacturers and slows the penetration of advanced endoscopic solutions in the global marketplace.

This financial pressure is exacerbated by rising operational costs that consume a growing portion of healthcare budgets. According to the American Hospital Association, total hospital expenses increased by 5.1% in 2024, significantly outpacing the general inflation rate. This economic strain compels decision-makers to prioritize essential daily operations over capital investments in surgical instrumentation. Consequently, the inability of many institutions to absorb these elevated costs reduces their purchasing power and hampers the overall growth of the rigid endoscopes market.

Market Trends

The migration of endoscopic procedures to Ambulatory Surgical Centers (ASCs) is reshaping the market landscape as providers seek cost-effective alternatives to inpatient care. This shift is particularly evident in rigid endoscopic interventions like arthroscopy and laparoscopy, where the streamlined workflows of ASCs facilitate higher throughput and lower overhead costs. Supportive reimbursement policies and the availability of compact, high-performance visualization systems designed for smaller environments further encourage this transition. As noted by the Ambulatory Surgery Center Association in July 2024, surgical procedure volume in ASCs is projected to rise by 21% to reach 44 million cases between 2024 and 2034, incentivizing manufacturers to create specialized service models and devices for the expanding outpatient sector.

Concurrently, the advancement of fluorescence-guided imaging systems is allowing surgeons to visualize anatomical structures with greater precision than standard white-light endoscopy affords. Technologies utilizing near-infrared fluorescence enable real-time assessment of tissue perfusion and bile duct identification during complex laparoscopic surgeries, driving demand for these sophisticated optical capabilities. This technological evolution addresses a critical need for improved intraoperative safety and is fueling revenue growth for major device manufacturers. According to Stryker Corporation's January 2025 report, the company's endoscopy business achieved double-digit organic sales growth globally for the full year 2024, highlighting the accelerating adoption of next-generation imaging platforms that integrate fluorescence capabilities to improve clinical outcomes.

Key Market Players

• Olympus Corporation
• Ethicon, Inc.
• Boston Scientific Corporation
• Karl Storz SE & Co. KG
• Stryker Corporation
• PENTAX Medical Singapore Pte Ltd
• Richard Wolf GmbH
• ATMOS MedizinTechnik GmbH & Co. KG
• XION GmbH
• EndoMed Systems GmbH

Report Scope

In this report, the Global Rigid Endoscopes Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Rigid Endoscopes Market, By Product

• Laparoscopes
• Arthroscopes
• Ureteroscopes
• Cystoscopes
• Gynecology Endoscopes
• Neuroendoscopes
• Bronchoscopes
• Hysteroscopes
• Laryngoscopes
• Sinuscopes
• Otoscopes
• Sigmoidoscopes
• Pharygnoscopes
• Duodenoscopes
• Nasopharygnoscopes
• Rhinoscopes

Rigid Endoscopes Market, By End User

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Rigid Endoscopes Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Rigid Endoscopes Market.

Available Customizations:

Global Rigid Endoscopes Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Rigid Endoscopes Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Laparoscopes, Arthroscopes, Ureteroscopes, Cystoscopes, Gynecology Endoscopes, Neuroendoscopes, Bronchoscopes, Hysteroscopes, Laryngoscopes, Sinuscopes, Otoscopes, Sigmoidoscopes, Pharygnoscopes, Duodenoscopes, Nasopharygnoscopes, Rhinoscopes)
  • 5.2.2. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Rigid Endoscopes Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Rigid Endoscopes Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By End User
  • 6.3.2. Canada Rigid Endoscopes Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By End User
  • 6.3.3. Mexico Rigid Endoscopes Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By End User

7. Europe Rigid Endoscopes Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Rigid Endoscopes Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By End User
  • 7.3.2. France Rigid Endoscopes Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By End User
  • 7.3.3. United Kingdom Rigid Endoscopes Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By End User
  • 7.3.4. Italy Rigid Endoscopes Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By End User
  • 7.3.5. Spain Rigid Endoscopes Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By End User

8. Asia Pacific Rigid Endoscopes Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Rigid Endoscopes Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By End User
  • 8.3.2. India Rigid Endoscopes Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By End User
  • 8.3.3. Japan Rigid Endoscopes Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By End User
  • 8.3.4. South Korea Rigid Endoscopes Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By End User
  • 8.3.5. Australia Rigid Endoscopes Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By End User

9. Middle East & Africa Rigid Endoscopes Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Rigid Endoscopes Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By End User
  • 9.3.2. UAE Rigid Endoscopes Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By End User
  • 9.3.3. South Africa Rigid Endoscopes Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By End User

10. South America Rigid Endoscopes Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Rigid Endoscopes Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By End User
  • 10.3.2. Colombia Rigid Endoscopes Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By End User
  • 10.3.3. Argentina Rigid Endoscopes Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Rigid Endoscopes Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Olympus Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Ethicon, Inc.
• 15.3. Boston Scientific Corporation
• 15.4. Karl Storz SE & Co. KG
• 15.5. Stryker Corporation
• 15.6. PENTAX Medical Singapore Pte Ltd
• 15.7. Richard Wolf GmbH
• 15.8. ATMOS MedizinTechnik GmbH & Co. KG
• 15.9. XION GmbH
• 15.10. EndoMed Systems GmbH

16. Strategic Recommendations

17. About Us & Disclaimer